Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03350997 · ClinicalTrials.gov registry record · NA
Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control
A NA study of Metabolic Disease and Adipose Tissue, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03350997: Completed NA study of Metabolic Disease and Adipose Tissue, sponsored by University of Michigan.
NCT03350997 is a NA study of Metabolic Disease and Adipose Tissue that has completed, run by University of Michigan. The registered enrollment target is 22 participants, below the 4,189-participant average among 33 other Metabolic Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03350997, a NA study of Metabolic Disease and Adipose Tissue, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team will assess "free-living" 24h glucose control using continuous glucose monitors (CGM) over an 88h period on two separate occasions. Importantly, standardized meals will be provided and will be consumed at specific times each day of the CGM measurement period. These meals will be identical on day 1 and day 3 of measurement. Each subject will complete two CGM periods, which will be identical except for the calorie and macronutrient content of the post-exercise dinner. In addition, during trial 1, two CGM's will be worn, while only 1 CGM will be worn on trial 2.
Primary Outcome
Average Post-prandial glucose values (1 hour, 2 hour, and 3 hours) will be measured
Conditions Studied
Interventions
- BEHAVIORAL Trial 2 Exercise
- BEHAVIORAL Trial 1 Exercise
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2016-10-21 |
| Est. Completion | 2017-12-18 |
| Phase | NA |
What the finished NCT03350997 record still lists
NCT03350997 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 4,189-participant average among 33 other Metabolic Disease trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Metabolic Disease appearing as the primary indexed condition, and to 2 interventions - of which Trial 2 Exercise is the first listed.
NCT03350997 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03350997 about?
NCT03350997 is a clinical study titled "Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control". The study team will assess "free-living" 24h glucose control using continuous glucose monitors (CGM) over an 88h period on two separate occasions. Importantly, standardized meals will be provided and will be consumed at specific times each day of the CGM measurement period. These meals will be ident...
What is the current status of trial NCT03350997?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-10-21. Estimated completion is 2017-12-18.
What conditions does trial NCT03350997 study?
This clinical trial studies the following conditions: Metabolic Disease, Adipose Tissue.
What interventions are being tested in trial NCT03350997?
The interventions under investigation include: Trial 2 Exercise (BEHAVIORAL), Trial 1 Exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03350997?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03350997 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03350997's enrollment target sits among peer trials
22 30th of 33 higher than 4 of 33 other Metabolic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Countermeasures to Circadian Misalignment
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes
RECRUITING · NA
-
HIIT Effects on Cardiometabolic Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI